|
! J
<br /> 0 #TA'
<br /> OPR Results EPA METHOD 1613
<br /> Matrix Effluent QC Batch No 3319 Lab Sample 0-0PR001
<br /> Sample Size 1 000 L Date Extracted 19-Sep-02 Date Analyzed DB-5 21-Sep-02 Date Analyzed DB-225 NA
<br /> Analyte Spike Cone Conc (ng/mL) OPR Limits Labeled Standard %R LCL-UCL
<br /> 2,3,7,8-TCDD 100 966 6 7- 158 IS 13C-2,3,7,8-TCDD 729 20- 175
<br /> 1,2,3,7,8-PeCDD 500 516 35-71 l3C-1,2,3,7,8-PeCDD 757 21 -227
<br /> 1,2,3,4,7,8-HxCDD 500 506 35-82 13C-1,2,3,4,7,8-HxCDD 635 21 - 193
<br /> 1,2,3,6,7,8-HxCDD 500 514 38-67 13C-1,2,3,6,7,8-HxCDD 706 25- 163
<br /> 1,2,3,7,8,9-HxCDD 500 519 32-81 13C-1,2,3,4,6,7,8-HpCD 655 26- 166
<br /> 1,2,3,4,6,7,8-HpCDD 500 53 5 35-70 13C-OCDD 684 26-397
<br /> OCDD 100 108 78- 144 13C-2,3,7,8-TCDF 865 22- 152
<br /> 2,3,7,8-TCDF 100 937 75- 158 13C-1,2,3,7,8-PeCDF 765 21 - 192
<br /> 1,2,3,7,8-PeCDF 500 529 40-67 13C-2,3,4,7,8-PeCDF 826 13 -328
<br /> 2,3,4,7,8-PeCDF 500 540 34-80 13C-1,2,3,4,7,8-HxCDF 55 1 19-202
<br /> 1,2,3,4,7,8-HxCDF 500 542 36-67 13C-1,2,3,6,7,8-HxCDF 552 21 - 159
<br /> 1,2,3,6,7,8-HxCDF 500 555 42-65 13C-2,3,4,6,7,8-HxCDF 635 22- 176
<br /> 2,3,4,6,7,8-HxCDF 500 560 35-78 13C-1,2,3,7,8,9-HxCDF 665 17-205
<br /> 1,2,3,7,8,9-HxCDF 500 538 39-65 13C-1,2,3,4,6,7,8-HpCD 65 1 21 - 158
<br /> 1,2,3,4,6,7,8-HpCDF 500 535 41 -61 13C-1,2,3,4,7,8,9-HpCD 673 20- 186
<br /> 1,2,3,4,7,8,9-HpCDF 500 526 39-69 13C-OCDF 673 26-397
<br /> OCDF 100 107 63- 170 CRS 37C1-2,3,7,8-TCDD 970 31 - 191
<br /> Analyst JMH Approved By William J Luksemburg 23-Sep-2002 13 41
<br /> Project 22791 Page 5 of 11
<br />
|